Smit C - Search Results

1

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies.

Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration. Sacks-Davis R, et al. Among authors: smit c. Lancet HIV. 2024 Feb;11(2):e106-e116. doi: 10.1016/S2352-3018(23)00267-9. Epub 2024 Jan 12. Lancet HIV. 2024. PMID: 38224708

2

Declining AIDS mortality in Amsterdam: contributions of declining HIV incidence and effective therapy.

Smit C, Geskus R, Uitenbroek D, Mulder D, Van Den Hoek A, Coutinho RA, Prins M. Smit C, et al. Epidemiology. 2004 Sep;15(5):536-42. doi: 10.1097/01.ede.0000135171.07103.f0. Epidemiology. 2004. PMID: 15308952

3

Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour.

Smit C, Lindenburg K, Geskus RB, Brinkman K, Coutinho RA, Prins M. Smit C, et al. Addiction. 2006 Mar;101(3):433-40. doi: 10.1111/j.1360-0443.2006.01339.x. Addiction. 2006. PMID: 16499516

4

Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study.

Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. Lindenburg CE, et al. Among authors: smit c. AIDS. 2006 Aug 22;20(13):1771-5. doi: 10.1097/01.aids.0000242824.59377.53. AIDS. 2006. PMID: 16931942

5

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

van den Berg CH, Smit C, Bakker M, Geskus RB, Berkhout B, Jurriaans S, Coutinho RA, Wolthers KC, Prins M. van den Berg CH, et al. Among authors: smit c. Eur J Epidemiol. 2007;22(3):183-93. doi: 10.1007/s10654-006-9089-7. Epub 2007 Mar 3. Eur J Epidemiol. 2007. PMID: 17334821 Free PMC article.

6

Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users.

Van Den Berg C, Smit C, Van Brussel G, Coutinho R, Prins M; Amsterdam Cohort. Van Den Berg C, et al. Among authors: smit c. Addiction. 2007 Sep;102(9):1454-62. doi: 10.1111/j.1360-0443.2007.01912.x. Addiction. 2007. PMID: 17697278 Free PMC article.

7

Risk of hepatitis-related mortality increased among hepatitis C virus/HIV-coinfected drug users compared with drug users infected only with hepatitis C virus: a 20-year prospective study.

Smit C, van den Berg C, Geskus R, Berkhout B, Coutinho R, Prins M. Smit C, et al. J Acquir Immune Defic Syndr. 2008 Feb 1;47(2):221-5. doi: 10.1097/QAI.0b013e31815d2f59. J Acquir Immune Defic Syndr. 2008. PMID: 18223361

8

Treatment of acute hepatitis C virus infection in HIV-infected MSM: the effect of treatment duration.

Lambers FA, Brinkman K, Schinkel J, Spijkerman IJ, Molenkamp R, Coutinho RA, Prins M, van der Meer JT; MOSAIC (MSM Observational Study of Acute Infection with hepatitis C) study group. Lambers FA, et al. AIDS. 2011 Jun 19;25(10):1333-6. doi: 10.1097/QAD.0b013e3283480144. AIDS. 2011. PMID: 21516025

9

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. Mocroft A, et al. PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar. PLoS Med. 2015. PMID: 25826420 Free PMC article.

10

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.

Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, Monforte Ad, Kirk O, Ryom L; Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study. Mocroft A, et al. Lancet HIV. 2016 Jan;3(1):e23-32. doi: 10.1016/S2352-3018(15)00211-8. Epub 2015 Nov 17. Lancet HIV. 2016. PMID: 26762990 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page